Gabelli Funds LLC

SEC CIK: 0001081407
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

RVNC holding history

Revance Therapeutics, Inc. in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVNC overview All 13F holders of RVNC Full Q2 2026 holdings

Shares (Q1 2025): 0; Sold out in Q1 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2024

Holdings of RVNC by Gabelli Funds LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2025	0	$0	0.0%	−1,262,487−100.0%	Sold out	Holders
Q4 2024	1,262,487	$3.84M	<0.1%	+171,323+15.7%	Added	Holders
Q3 2024	1,091,164	$5.66M	<0.1%	+1,091,164	New	Holders